Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesDurable Medical Equipment (DME)northwood PROSE/V2627 Coverage Update | OpenPayer
    Ask Trek AI about this page
    ModifiednorthwoodPolicy N/A

    Eye prosthesis (ocular prosthesis and related scleral devices)

    Customize your policy alerts

    Sign up for all northwood policy alerts

    Know when northwood releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs coverage and medical necessity criteria for eye prostheses and related services (e.g., polishing, enlargement, reduction, scleral cover shells, ocular conformers) for Northwood members across Medicare, Commercial, and NH Medicaid lines where applicable.

    Policy Summary
    Payernorthwood
    PolicyEye prosthesis (ocular prosthesis and related scleral devices)
    Policy CodePolicy N/A
    Change TypePlan-specific noncoverage addedoperational prior auth update
    Effective DateFeb 1, 2023
    Next Review DateNov 4, 2025
    Key ActionMaintain the ordering physician's signed initial order and supporting medical records on file and provide documentation on request.
    SourceLink
    POLICY UPDATE CHANGES

    For WellSense NH Medicaid QHP members, PROSE treatment and any scleral shell cover billed with HCPCS V2627 are considered experimental/investigational or not medically necessary for primary or secondary dry eye disease.

    Effective 2/1/2023, SCO was removed as an applicable product for this policy because prior authorization will no longer be required for SCO members.

    ICD-10 codes were added for HCPCS V2627.

    5replacement interval (yrs)
    2polishing/resurfacing per year
    V2623-V2628

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    HCPCS range referenced
    V2627specific HCPCS referenced
    WellSense NH Medicaid QHPplan noncoverage
    2/1/2023SCO prior auth effective

    Coverage and Medical Necessity Criteria

    inv-01: Coverage Criteria

    Covered when ALL of the following are met

    Basic Coverage Conditions: 1) Must be ordered by the member's treating practitioner. 2) Member has absence or shrinkage of an eye due to birth defect, trauma, or surgical removal.

    Medicare members: refer to Medicare policy L33737/A52462 for specific criteria.

    inv-02: PROSE / Scleral Cover Shell Indications

    PROSE device coding and medical necessity

    PROSE as V2627: When used to treat an eye rendered sightless and shrunken by inflammatory disease (ICD-10 H44.521-H44.529) OR when used as a substitute for lacrimal gland function for dry eye (ICD-10 H04.121-H04.129), code the device as V2627 (scleral cover shell).

    When used for indications other than the listed diagnoses, the device must be coded as V2531 (contact lens, scleral, gas permeable) and is subject to the Medicare refractive lens statutory coverage exclusion.

    inv-03: Plan-specific Noncoverage for Dry Eye Disease

    Not medically necessary/experimental for specific indication and plan

    WellSense NH Medicaid QHP V2627 stance: PROSE treatment and any scleral shell cover billed with HCPCS V2627 are considered experimental and investigational or not medically necessary when used for the treatment of primary or secondary dry eye disease.

    Applies to WellSense NH Medicaid QHP members as stated in policy.

    Trial scleral cover shells are not separately payable; they are included in the allowance for HCPCS V2627. Claims for trial shells submitted as separate billable items will be denied per the policy. When a PROSE® device is used for indications other than the two listed diagnoses (sightless/shrunken eye from inflammatory disease or PROSE as substitute for lacrimal gland function in dry eye), the device must be coded as V2531 (contact lens, scleral, gas permeable, per lens) rather than V2627 and is subject to the Medicare refractive lens statutory coverage exclusion.

    Use of HCPCS V2627 to bill PROSE® devices as treatment for primary or secondary dry eye (PROSE serving as substitute for lacrimal gland function; ICD-10 H04.121–H04.129) is a plan-specific coverage decision. For WellSense NH Medicaid QHP members, this use of V2627 is considered experimental, investigational, or not medically necessary and may be denied.

    For WellSense NH Medicaid QHP members, PROSE® treatment and other scleral shell covers billed with HCPCS V2627 for the treatment of primary or secondary dry eye disease are considered experimental and investigational or not medically necessary because of the limited quality of evidence supporting efficacy for this indication. Providers should expect denials when V2627 is used for dry eye in this product.

    PROSE® treatment and any scleral shell cover billed with HCPCS V2627 are treated as not medically necessary or experimental for treatment of primary or secondary dry eye disease for WellSense NH Medicaid QHP members. When PROSE® is used for the specific covered indications (sightless/shrunken eye from inflammatory disease, ICD-10 H44.521–H44.529), bill as V2627; when used for other indications, bill as V2531.

    Coding and Billing Codes

    Covered HCPCS Level II CodesHCPCSCovered
    V2623Prosthetic eye, plastic, custom
    V2624Polishing/resurfacing of ocular prosthesis
    V2625Enlargement of ocular prosthesis
    V2626Reduction of ocular prosthesis
    V2627Scleral cover shell
    V2628Fabrication and fitting of ocular conformer
    Alternate HCPCS for PROSE when not used for listed indicationsHCPCS
    V2531Contact lens, scleral, gas permeable, per lens (used for PROSE devices when not for listed indications)
    Referenced HCPCSHCPCS
    V2627Scleral shell cover / PROSE device (as referenced in policy)
    inv-11: Replacement interval — every 5 years
    Replacement intervalRoutine replacement permitted every 5 years; earlier replacement covered if irreparably damaged, lost, or stolen (documentation required).
    Documentation for replacementAn order for the initial eye prosthesis signed and dated by the ordering physician must be kept on file; ocularist documentation acceptable for replacement when not medically necessitated (e.g., accidental loss).
    Physician order not required for loss/damage reimbursementsReplacement because of loss or irreparable damage may be reimbursed without a physician's order if the original order still fills the member's medical needs.
    inv-12: N/A — placeholder key/value
    StatusN/A (placeholder).

    Provider Actions, Prior Authorization, and Billing Guidance

    Prior Authorization

    Medicare reference — check L33737/A52462; PA varies by product/line

    Refer to Medicare medical policy L33737 and article A52462 for Medicare coverage criteria; prior authorization requirements may vary by product/line of business and by plan.

    Prior Authorization

    SCO prior authorization removed effective 2/1/2023

    SCO (Special Needs) membership is no longer an applicable product for prior authorization under this policy effective 2/1/2023; prior authorization implications remain plan-dependent for other products.

    Documentation Required

    Keep signed, dated order and medical records on file

    Background

    An eye prosthesis is an artificial replacement for an absent or shrunken eye. Scleral cover shells — including PROSE® devices when used for specific indicated diagnoses — rest on the sclera and are used to treat a shrunken, sightless eye caused by inflammatory disease or to substitute for lacrimal gland function in select dry eye diagnoses. Coverage and coding depend on the clinical indication: for the two listed indications, PROSE® is coded as V2627; for other conditions, it should be coded as V2531.

    Definitions

    inv-22: Eye prosthesis — artificial replacement of an eye
    DefinitionAn eye prosthesis is an artificial replacement of an eye.
    IndicationsUsed after birth defects, trauma, surgical removal, or shrinkage of an eye.
    Related HCPCSCovered HCPCS for prosthetic eye includes V2623 (prosthetic eye, plastic, custom).
    inv-23: PROSE device / scleral cover shell coding — PROSE devices rest on sclera and may be coded as V2627 or V2531
    DefinitionPROSE devices are designed to rest on the sclera and are used to treat ocular surface diseases; when used for listed indications they are coded as V2627; when used for other conditions they must be coded as V2531.
    Coding noteIf used for indications other than the listed diagnoses, PROSE devices must be coded with HCPCS V2531 and are subject to Medicare refractive lens exclusion.

    Medical Necessity Criteria and Adjustment Procedures

    inv-25: DME Medical Necessity

    Covered when clinical indications are documented

    General DME Medical Necessity: Ordered by the treating practitioner AND member has absence or shrinkage of an eye due to birth defect, trauma, or surgical removal.

    Medicare members should follow Medicare policy L33737/A52462 for detailed criteria.

    inv-26: Adjustment Procedures

    Adjustments to prosthesis

    Enlargement/Reduction: One enlargement (V2625) and one reduction (V2626) of an ocular prosthesis are covered without documentation. Additional enlargements or reductions require medical record documentation supporting medical necessity and must be available on request.

    inv-27: Medical Necessity — Plan Specific

    Plan-specific denial for dry eye disease when billed with V2627

    Rental, Purchase, and DMEPOS Rules

    Equipment/RuleBilling rule / Notes
    {"text":"General DMEPOS","status":""},{"text":"Policy note: DMEPOS items primarily for non-medical purposes are not considered DME. Coverage determinations are contract-dependent and subject to terms, conditions, limitations, and exclusions. Policies provide criteria approved by Northwood's Medical Director. Capped rental rules apply per member contract and Medicare/NCD/LCD guidance.","status":""}
    HCPCS / ItemPlan applicability / Notes
    {"text":"V2627 — Scleral cover shell (PROSE device)","status":""},{"text":"For WellSense NH Medicaid QHP members: use of PROSE and any scleral shell billed with V2627 for primary or secondary dry eye disease is considered experimental/investigational or NOT medically necessary and may be denied. Documentation/coding guidance updated; ICD‑10 codes were added for V2627. SCO: effective 2/1/2023 SCO was removed as an applicable product for this policy (prior authorization no longer required for SCO members).","status":""}

    Replacement, Polishing, and Service Frequency

    inv-30: ocular prosthesis — replacement interval every 5 years
    Replacement intervalRoutine replacement permitted every 5 years for ocular prosthesis.
    ExceptionsReplacement prior to 5 years covered if documentation supports medical necessity or if prosthesis is irreparably damaged, lost, or stolen.
    Reimbursement for loss/damageReplacement due to loss or irreparable damage may be reimbursed without a physician's order if the original order remains appropriate.
    inv-31: polishing/resurfacing (V2624) — twice per year
    Frequency coveredPolishing/resurfacing of ocular prosthesis (V2624) is covered up to twice per year.
    HCPCSV2624 = Polishing/resurfacing of ocular prosthesis.

    Documentation Requirements

    Documentation Required

    Keep physician order and medical records available

    Maintain the signed and dated order for the initial eye prosthesis and supporting medical records on file and provide documentation upon request to substantiate medical necessity.

    • Keep the ordering practitioner’s signed order on file.
    • Ensure medical records document the clinical indications for the device.
    Documentation Required

    Attach ICD-10 diagnosis codes when billing V2627

    Attach appropriate ICD-10 diagnosis codes when billing HCPCS code V2627 according to the updated coding guidance; ICD-10 codes were added for V2627 in the policy history.

    Non-Covered Items

    Not covered: trial scleral cover shells billed separately are excluded because trial shells are included in the allowance for V2627. Additionally, when PROSE® or other scleral shell covers are billed as V2627 for the treatment of primary or secondary dry eye disease in WellSense NH Medicaid QHP members, the service is considered experimental, investigational, or not medically necessary and may be denied.

    Revision History and Policy Changes

    2023-02-01operationalLatest

    SCO was removed as an applicable product for this policy and will no longer require prior authorization for SCO members.

    2022-11-30coding_update

    ICD-10 diagnosis codes were added for HCPCS code V2627 (PROSE/scleral shell).

    2022-11-10annual_review
    Policy Summary
    Payernorthwood
    PolicyEye prosthesis (ocular prosthesis and related scleral devices)
    Policy CodePolicy N/A
    Change TypePlan-specific noncoverage addedoperational prior auth update
    Effective DateFeb 1, 2023
    Next Review DateNov 4, 2025
    Key ActionMaintain the ordering physician's signed initial order and supporting medical records on file and provide documentation on request.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaCoding and Billing CodesProvider Actions, Prior Authorization, and Billing GuidanceBackgroundDefinitionsMedical Necessity Criteria and Adjustment ProceduresRental, Purchase, and DMEPOS RulesReplacement, Polishing, and Service FrequencyDocumentation RequirementsNon-Covered ItemsRevision History and Policy Changes
    NotesNo specific threshold or interval provided in policy text for this entry.
    ActionNo action required; retained as placeholder per inventory.

    Maintain the ordering practitioner’s signed and dated order and supporting medical records on file to substantiate medical necessity for the initial prosthesis and any covered procedures.

    • Initial order must be signed and dated by the ordering physician/treating practitioner.
    • Physician records must support medical necessity for the item ordered.
    Note
    Documentation Required

    Ocularist documentation acceptable for replacement claims when non‑medical

    Ocularist documentation is acceptable evidence for replacement prosthesis claims when replacement is due to non‑medical reasons (e.g., accidental loss); additional enlargements/reductions require documentation available on request.

    • Ocularist documentation suffices for replacements prompted by accidental loss.
    • Additional enlargement/reduction procedures must be supported by medical records on request.
    Documentation Required

    Attach appropriate ICD‑10 codes when billing V2627 (coding update)

    ICD‑10 diagnosis codes were added for HCPCS code V2627; attach the appropriate ICD‑10 codes when billing V2627 per updated coding guidance.

    Billing Rule

    Use RT/LT modifiers correctly — claims without correct side modifiers will be rejected

    Claims billed without the RT and/or LT modifiers, or with RTLT on the same claim line billed with 2 units of service, will be rejected as incorrect coding.

    • When the same code for bilateral items is billed on the same DOS, bill two separate claim lines using RT and LT with 1 UOS each.
    • Do not use RTLT on the same claim line with 2 UOS.
    Denial Risk

    Plan‑specific denial risk: V2627 billed for dry eye disease may be denied for WellSense NH Medicaid QHP

    Use of HCPCS V2627 (PROSE/scleral shell) for treatment of primary or secondary dry eye disease is considered experimental/investigational or not medically necessary for WellSense NH Medicaid QHP members and may be denied.

    • This is a plan‑specific denial risk that applies to WellSense NH Medicaid QHP members.
    Examples of listed indicationsSightless, shrunken eye due to inflammatory disease (H44.521-H44.529) or as substitute for lacrimal gland function for dry eye (H04.121-H04.129).
    inv-24: PROSE / V2627 — PROSE treatment and scleral shell cover billed with HCPCS V2627 used in ocular surface disease contexts
    DescriptionPROSE treatment and scleral shell cover billed with HCPCS V2627 are scleral prosthetic devices used in ocular surface disease contexts (e.g., shrunken sightless eye from inflammatory disease or as lacrimal substitute for dry eye).
    Plan-specific restrictionFor WellSense NH Medicaid QHP members, use of V2627 for primary or secondary dry eye disease is considered experimental/not medically necessary and may be denied.
    Coding requirementWhen used for listed indications, code V2627; when used for other conditions, code V2531.
    WellSense NH Medicaid QHP exclusion: Use of HCPCS V2627 for primary or secondary dry eye disease is considered experimental and not medically necessary for WellSense NH Medicaid QHP members.

    This is a plan-specific coverage decision as stated in the policy.

    DocumentationMaintain medical records supporting necessity as required; usual physician order requirements apply for initial prosthesis.
    inv-32: Eye prosthesis / V2627 — replacement/coverage notes (empty summary in inventory)
    Policy noteEye prosthesis / V2627 — policy references V2627 for scleral cover shells and documents coding guidance and plan-specific applicability.
    Replacement intervalNo specific replacement interval for V2627 is specified in this policy fragment.
    Coding/documentation updateICD-10 codes were added for HCPCS V2627 per change history; attach appropriate diagnosis codes when billing as indicated.

    Annual review completed with no further clinical changes documented on that date.

    2022-03-07content_update

    'Special Coverage Information per Plan' box added to clarify QHP and SCO/SNP plan-specific applicability and code V2627 references.

    2019-11-19coding_and_billing_update

    Revised RT and LT modifier billing instructions and updated coding guidelines for the PROSE device.